Skip to main content
. 2020 Aug 27;11:537265. doi: 10.3389/fphar.2020.537265

Figure 5.

Figure 5

YAP/TAZ insufficiency (p=0.028, OR=0.261, 95%CI 0.081–0.927) and positive HR status (p=0.036, OR=0.751, 95%CI 0.279–0.938) contributed to reduce relapse risk of breast cancer.